Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.87 - $1.71 $1.11 Million - $2.17 Million
1,270,920 Added 210.44%
1,874,843 $3.21 Million
Q2 2023

Aug 11, 2023

SELL
$0.83 - $1.18 $1.9 Million - $2.7 Million
-2,284,358 Reduced 79.09%
603,923 $694,000
Q1 2023

May 12, 2023

SELL
$0.8 - $4.98 $66,784 - $415,735
-83,481 Reduced 2.81%
2,888,281 $2.34 Million
Q4 2022

Feb 13, 2023

SELL
$1.88 - $2.49 $512,187 - $678,375
-272,440 Reduced 8.4%
2,971,762 $7.07 Million
Q3 2022

Nov 14, 2022

BUY
$2.5 - $4.77 $683,600 - $1.3 Million
273,440 Added 9.2%
3,244,202 $7.37 Million
Q2 2022

Aug 12, 2022

BUY
$1.75 - $11.34 $771,751 - $5 Million
441,001 Added 17.43%
2,970,762 $7.28 Million
Q1 2022

May 12, 2022

BUY
$10.21 - $20.29 $337,593 - $670,888
33,065 Added 1.32%
2,529,761 $25.8 Million
Q4 2021

Feb 10, 2022

BUY
$16.76 - $22.99 $5.9 Million - $8.09 Million
352,027 Added 16.41%
2,496,696 $49.2 Million
Q3 2021

Nov 09, 2021

BUY
$13.15 - $22.56 $8.29 Million - $14.2 Million
630,696 Added 41.66%
2,144,669 $39.7 Million
Q2 2021

Aug 11, 2021

BUY
$18.28 - $33.05 $27.7 Million - $50 Million
1,513,973 New
1,513,973 $27.7 Million

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0

About Praxis Precision Medicines, Inc.


  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $1.79B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.